INTRODUCTION {#sec1-1}
============

*Helicobacter pylori (H. Pylori)* infection is high prevalence particularly in underdeveloped and developing countries.[@ref1][@ref2][@ref3][@ref4] It affects about 90% of adult persons in some countries.[@ref5] In Iran, prevalence of the infection in adults is estimated to be about 70-80%.[@ref6][@ref7] The infection is a basic risk factor for chronic gastritis, peptic ulcer and gastric adenocarcinoma,[@ref8][@ref9][@ref10][@ref11][@ref12] which is the most common malignancy in north and northwest Iran.[@ref7]

*H. pylori* has several lipopolysaccharides such as O antigen on its outer membrane expressing Le^a^ and Le^b^ antigens. The Lewis antigen expression on the membrane of *H. pylori* for antigenic mimicry may create persistent colonisation and surviving of bacteria in the stomach mucosa. In addition, expression of Le^b^ antigens in gastric mucosa may play as a receptor for bacterial adhesion. It seems blood group antigen b-binding adhesion (*babA*) on the outer membrane of *H. pylori* has a major role in persistent colonisation of the bacteria with attachment to Le^b^ antigens of gastric mucosa.[@ref13][@ref14] Binding of *H. pylori* to H and Le^b^ antigens in gastric mucosa probably describes higher incidence of chronic gastritis and gastric adenocarcinoma in O blood group phenotype and secretors (expressing Le^b^ antigen).[@ref15][@ref16]

Some other reports, however, have not determined any association between the infection and the Lewis[@ref5] and ABO blood groups.[@ref17] Some heterogeneity has been characterised in expression of the outer membrane protein, especially *babA*, that describes various capacities of different *H. pylori* for adhesion to Le^b^ antigen on the gastric mucosa, a factor determining some differences in clinical outcomes of the infection.[@ref18][@ref19] Based on controversial associations between *H. pylori* infection and these blood groups and the fact that *H. pylori* infection and gastric adenocarcinoma are the frequent diseases in developing countries, the assessment of the association of the infection with the blood groups would be valuable.

MATERIALS AND METHODS {#sec1-2}
=====================

The study was ethically approved by Vice President for research and the local ethical committee in Mashhad University of Medical Sciences, Iran. In a cross-sectional study from 2009 to 2010, we evaluated adult dyspeptic patients referred to the nuclear medicine laboratory of Imam Reza hospital (a major teaching hospital located in Mashhad, northeast Iran) from various gastrointestinal clinics for ^14^C-urea breath test (UBT). Based on medical history, patients who had received H2 receptor antagonists, proton-pump inhibitors and antibiotics within the last 4 weeks of conducting the study, were excluded to avoid false negative results. We also excluded pregnant or breast feeding women from the study. After exclusions, first a UBT was performed and then the blood ABO, Rh (D) and Lewis phenotypes of the remaining 135 patients were determined.

Current infection with *H. pylori* was detected by using the Heliprobe system ^14^C-UBT (Kibion-sweden™). After 10-20 minutes of ingestion of a capsule containing ^14^C-urea, the patients exhaled into the Breath Card until a pH-sensitive indicator altered color from orange to yellow because of CO~2~ saturation of the pads. Then, the BreathCards were put into a Heliprobe analyser and the radioactivities of the samples were measured. Finally, the results were mentioned in a numerical order: 0 as not infected (radioactivity as count per minute (CPM) \<25, 1 as borderline result (25-50 CPM) and 2 as infected (\>50 CPM). Borderline results were disregarded in comparative analysis.

After getting written informed consent, 2 mL blood for blood group typing was taken. ABO, Rh (D) and Lewis phenotypes were typed by commercial antibodies using direct tube agglutination test according to manufacturer\'s instructions (Biotest™, Germany). Based on expression or non-expression of Le^b^ antigen, subjects were divided to secretor and non-secretor groups, respectively. Secretion status cannot be inferred from Le (a−b−) phenotype (*n* = 33); therefore, it was ignored in the evaluation of secretion phenotype.[@ref15]

Statistical analysis {#sec2-1}
--------------------

Descriptive analysis of the demographic features, the frequencies of ABO, Le^a^ and Le^b^ antigens, the Lewis phenotypes and *H. pylori* infection were performed. Association of the Lewis antigens and the Lewis and ABO phenotypes with *H. pylori* infection was analysed by Fisher\'s exact test, and means of continuous variables were compared with independent sample *t*-test. A P ≤ 0.05 was considered as a significant level. All data were analysed by Statistical Package for the Social Sciences (SPSS) software (version 11.5).

RESULTS {#sec1-3}
=======

We studied 135 dyspeptic patients including 59 (43.7%) males and 76 (56.3%) females with an age range of 18-78 years and a mean (±SD) of 40 (±13) years. Out of all cases, 68 (50.4%) patients were positive for *H. pylori* infection, 54 (40%) patients were negative and 13 (9.6%) patients had borderline results. We didn\'t find a significant association between age and *H. pylori* infection (*P* = 0.666); however, the infection was more common in females than males (*P* = 0.024). The most common phenotype in the ABO groups was O (41.5%) followed by A (28.9%), B (25.2%) and AB (4.4%) and the most common phenotype in the Lewis groups was Le (a−b+) (53.4%) followed by Le (a−b−) (24.4%), Le (a+b−) (14.1%) and Le (a+b+) (8.1%).

As shown in [Table 1](#T1){ref-type="table"}, the frequencies of the ABO, Lewis and secretion phenotypes did not show a significant difference between infected and non-infected patients. We also did not find a significant difference between Le^a^ and Le^b^ antigens with the infection (*P* = 0.830).
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DISCUSSION {#sec1-4}
==========

There are many examples showing importance of blood groups in pathogenesis of some diseases. The role of blood groups in pathogenesis of norovirus, cholera and malaria infection is only a few examples.[@ref20] For the expression of ABH antigens, the first step is the synthesis of the H or group O antigen and then glycosyltransferases synthesise A and B antigens. Synthesis of the Lewis antigens is biochemically related to ABO antigens. The secretor gene (Se) express a fucosyltransferase II adding fucose to the terminal galactose of the type 1 precursor chain and forms type 1 H chain. Fucosyltransferase type III, the product of the Lewis gene, adds fucose to type 1 precursor chains and forms the Le^a^ antigen or type 1 H chain and forms the Le^b^ antigen. As a result, subjects lacking the *Se* gene, non-secretors, can\'t form type 1H chain and antigens derived from it (Le^b^).[@ref11][@ref12][@ref17] Hence, non-secretors can only form the Le^a^ antigen.[@ref20][@ref21]

Diagnosis of *H. pylori* can be made by various invasive methods such as biopsy for a rapid urease test, culture and polymerase chain reaction and non-invasive methods such as serum *H. pylori* IgG antibody titer and UBT. The ^14^C-UBT (Heliprobe system) is an easy and rapid way with sensitivity of 94% and specificity of 100% for diagnosis of *H. pylori* infection in patients with dyspeptic complaints.[@ref22][@ref23]

Many studies have shown adherence of *H. pylori* to H and Le^b^ antigens (secretors) in gastric mucosa and *babA* on the outer membrane of *H. pylori* mediates adherence of *H. pylori* to Le^b^ antigens expressed on the mucosa.[@ref13][@ref24][@ref25] This may cause high incidence of chronic gastritis and gastric adenocarcinoma in the O and Le (a−b+) phenotypes.[@ref21] However, in our research, we did not determine any association between ABO and Lewis phenotypes with this infection. de Mattos *et al*., studied the association between the ABO and Lewis blood group and secretor status in 120 infected and non-infected patients by *H. pylori* by using breath and urease tests. They showed *H. pylori* is more frequent in the O blood group but not in the Lewis nor in the secretors.[@ref5] In another study, Heneghan *et al*., determined the Lewis and ABO phenotypes on 207 patients during gastric endoscopy and culture for *H. pylori* infection; like our findings, they did not characterise any relationship between these phenotypes or secretor status with *H. pylori* infection.[@ref26] In contrast to many other findings, Rothenbacher *et al*., demonstrated higher frequency of *H. pylori* infection in Le (a+b−) phenotype compared with Le (a−b+).[@ref13] Perhaps part of the differences in the results across studies is due to the number of patients included, especially the difference with Rothenbacher study may be due to different criteria. Rothenbacher study included only immediate postpartum period and breast feeding women, while in our study, this population was excluded.

These data show that the association of ABO and Lewis antigens and, secretor status with *H. pylori* infection is controversial. Recent studies have tried to resolve this controversy. Based on some findings, strains of *H. pylori* from various areas of the world differed about 1,500-fold in binding affinity to O antigen, because of diversity in *babA* gene sequences.[@ref18][@ref20][@ref27] Accordingly, all strains are not so specific for O and Le^b^. In a study in Sweden, Aspholm-Hurtig *et al*., considered that more than 95% of adherent strains bind to A, B, and also O antigens whereas only 60% of adherent strains in South American Amerindian adhere better to O antigen. Many strains from outside South America have binding capabilities for A and Le^b^ in addition to O and Le^b^.[@ref20][@ref27] Con *et al*., characterised a higher frequency of *babA2* in Japan (96.8%) than in Costa Rica (73.7%) by genotyping of 95 Costa Ricans and 95 Japanese *H. pylori* isolates; however, *babA2/B* was higher in Costa Rican (11.6%) than in the Japanese (1.1%). They suggested that *babA2* and *babA2/B* had geographic diversities.[@ref28]

*SabA*, a sialic acid-binding adhesion, is another virulence factor in *H. pylori* determined lately. It also has geographic diversity and is more frequent in European than Japanese *H. pylori* isolates.[@ref29][@ref30] The *babA* distinguishes both H-type 1 and Lewis B blood-group antigens on gastric mucosa of secretor persons, initiating the first steps of the infection. After that, persistent infection results in inflammatory reaction with concomitantly expression of sialylated antigens. Furthermore, the *SabA* causes *H. pylori* binding to gastric mucosa by sialyl-Lewis^a^ and sialyl-Lewis x antigens.[@ref25] A limitation of the study was lack of genotype determination of *H. pylori*. We suggest the determination of virulence factors of *H. pylori* such as *babA* and *SabA* in other study in addition to ABO and Lewis antigens.

CONCLUSION {#sec1-5}
==========

We did not establish a significant association between the Lewis, ABO or secretion phenotypes with *H. pylori* infection. Diversity in *babA* gene sequences of *H. pylori* can probably describe why our results were different from others in other geographic areas.
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